Australian Health Alert Warns Travellers Over Counterfeit Rabies Vaccine in India

Australian health authorities have issued a critical warning for travellers. The alert concerns a counterfeit rabies vaccine found in India. The Australian Technical Advisory Group on Immunisation (ATAGI) released the advice on December 19.

It states that fake batches of the vaccine “Abhayrab” have circulated since late 2023. Travellers who received this vaccine in India after November 1, 2023, should consider their vaccination invalid. They are advised to begin a fresh immunisation course immediately.

Manufacturer Disputes Scope of Australian Warning

The vaccine’s manufacturer has strongly contested the advisory’s breadth. Indian Immunologicals Limited (IIL) called the warning “over-cautionary and misplaced.” According to Reuters, the company clarified the issue is limited to one specific batch.

IIL identified a packaging anomaly in Batch No. KA24014 in January 2025. They reported it to Indian regulators and law enforcement promptly. The company insists this is an isolated incident in its 25-year history.

No other counterfeit batches are known. The affected batch is no longer on the market. IIL has urged ATAGI to revise its guidance to prevent public anxiety.

Broader Impact on Travel Health and Vaccine Trust

This incident highlights challenges in global medical supply chains. Travellers must verify their healthcare sources abroad carefully. The discrepancy between a national health advisory and a manufacturer’s statement can confuse the public.

Rabies is nearly always fatal after symptoms begin. Prevention through effective vaccination is vital. The situation underscores the importance of robust pharmacovigilance systems worldwide.

For Australian travellers, the advice remains clear. Consulting a travel medicine specialist before any trip to rabies-endemic regions is essential. They can provide verified vaccines and clear post-exposure guidance.

The ongoing dialogue between ATAGI and the vaccine manufacturer is crucial. It will shape final guidance for international travellers regarding the rabies vaccine. Ensuring accurate public health information protects everyone.

Info at your fingertips

Q1: What should I do if I got a rabies shot in India recently?

If you received an Abhayrab vaccine in India after November 1, 2023, consult your doctor. ATAGI advises starting a new vaccination course. Do not assume you are protected.

Q2: Is the Abhayrab vaccine itself unsafe?

No. The manufacturer states its genuine product is safe and effective. The issue involves specific counterfeit batches impersonating the real vaccine. Authentic supplies from authorized channels are considered reliable.

Q3: How can I ensure my travel vaccines are genuine?

Get vaccinated at reputable travel clinics in your home country before departure. If requiring care abroad, use major hospitals or clinics with international accreditation. Always keep a detailed record of your vaccinations.

Q4: How common is rabies in travellers?

Rabies infection in travellers is very rare. However, the potential exposure risk from animal bites in endemic countries is significant. Pre-travel vaccination is a key preventive measure recommended by health authorities globally.

Q5: What has the Indian regulator said about this?

The Delhi Drugs Control Department issued a notification in March 2025. It pertained specifically to the single counterfeit batch (KA24014). This official notification was referenced in the Australian advisory.

Trusted Sources

Information in this report was compiled from official statements by the Australian Technical Advisory Group on Immunisation (ATAGI) and Indian Immunologicals Limited. Additional context was provided by reporting from Reuters and PTI (Press Trust of India).

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional for personal health decisions and travel vaccinations.